What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2025-08-01 compared with 2025-05-02 · 99 added, 72 removed, 213 unchanged (45% of the section changed)

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of the Company’s financial condition and results of operations, which we refer to as our “MD&A,” should be read in conjunction with the Condensed Consolidated Financial Statements and the notes thereto contained in this Quarterly Report on Form 10-Q (this "Form 10-Q"), as well as the MD&A section included in our 2024 Form 10-K.

Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

8 unchanged sentences

the potential effects of inflationary pressures, tariffs or the imposition of new tariffs, trade wars, barriers or restrictions, or threats of such actions, changes in interest rates, labor market shortages and supply chain issues;

instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed regulatory, trade or other policies of the U.S., and the conflict between Russia and Ukraine, the conflict in Israel and Gaza and related uncertainty in the surrounding region, and the possible expansion of such conflicts;

instability or volatility in financial markets or other unfavorable economic or business conditions caused by geopolitical concerns, including as a result of new or proposed legislation or regulatory, trade or other policies in or impacting the U.S., the conflict between Russia and Ukraine, the conflicts in Israel, Gaza and Iran, related uncertainty in the surrounding region, and the possible expansion of such conflicts;

the effect of any of the foregoing on our customers’ demand for our products and our suppliers’ ability to manufacture and deliver our raw materials, including implications of reduced refinery utilization in the U.S.;

29 unchanged sentences

Business Overview

AdvanSix is a diversified chemistry company playing a critical role in global supply chains, innovating and delivering essential products for our customers in a wide variety of end markets and applications that touch people’s lives, such as building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives and electronics.

and sustainable supply of quality products emerges from the integrated value chain of our five U.S.-based manufacturing facilities.

AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients and chemical intermediates, guided by our core values of Safety, Integrity, Accountability and Respect.

AdvanSix is a diversified chemistry company that produces essential materials for our customers in a wide variety of end markets and applications that touch people’s lives.

Our integrated value chain of our five U.S.-based manufacturing facilities plays a critical role in global supply chains and enables us to innovate and deliver essential products for our customers across building and construction, fertilizers, agrochemicals, plastics, solvents, packaging, paints, coatings, adhesives, electronics and

other end markets.

Guided by our core values of Safety, Integrity, Accountability and Respect, AdvanSix strives to deliver best-in-class customer experiences and differentiated products in the industries of nylon solutions, plant nutrients, and chemical intermediates.

Our key product lines are as follows:

4 unchanged sentences

We internally polymerize caprolactam into Aegis® Nylon 6 Resins, and we also market and sell the caprolactam that is not consumed internally to customers who use it to manufacture polymer resins to produce fibers, compounds and other nylon products.

Our Hopewell, VA manufacturing facility is one of the world’s largest single-site producers of caprolactam as of March 31, 2025.

Our Hopewell, VA manufacturing facility is one of the world’s largest single-site producers of caprolactam as of June 30, 2025.

• Plant Nutrients – Our ammonium sulfate is used by customers as a fertilizer containing nitrogen and sulfur, two key plant nutrients.

Ammonium sulfate fertilizer is derived from the integrated operations at the Hopewell manufacturing facility.

Because of our Hopewell facility’s size, scale and technology design, we are the world’s largest single-site producer of ammonium sulfate fertilizer as of March 31, 2025.

Because of our Hopewell facility’s size, scale and technology design, we are the world’s largest single-site producer of ammonium sulfate fertilizer as of June 30, 2025.

We market and sell ammonium sulfate primarily to North American and South American distributors, farm cooperatives and retailers to fertilize crops.

2 unchanged sentences

Most significant is acetone which is used by our customers in the production of solvents, paints, coatings, adhesives, resins and herbicides.

Other intermediate chemicals that we manufacture, market and sell include phenol, alpha-methylstyrene ("AMS"), cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines.

Other intermediate chemicals that we manufacture, market and sell include phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines.

Additional end-products for intermediates include automotive components, and water treatment and pharmaceutical intermediates.

11 unchanged sentences

We also directly supply packaged ammonium sulfate to customers, primarily in North and South America, and have diversified and optimized our offerings to include spray-grade adjuvants to support crop protection, as well as other specialty fertilizers and products for industrial use.

We produce ammonium sulfate fertilizer continuously throughout the year as part of our manufacturing process, but quarterly sales fluctuate reflecting both geographical and product sales mix considerations based on the timing and length of the growing seasons in North and South America.

North American ammonium sulfate demand and pricing, particularly for our higher-value granular product, are typically strongest during second quarter fertilizer application and then typically decline seasonally with new season fill in the third quarter.

Ammonium sulfate industry prices in the corn belt have declined approximately 10% from the second quarter to the third quarter, on average, since 2016.

Due to the ammonium sulfate fertilizer sales cycle, we

occasionally build up higher inventory balances because our production is continuous and not tied to seasonal demand for fertilizers.

Our ammonium sulfate fertilizer experiences quarterly sales seasonality reflecting both geographical and product sales mix considerations based on the timing and length of the growing seasons in North and South America.

The North American fertilizer season typically runs from July, when the value chain begins restocking fertilizer, through June of the following year, when most application for the year’s planting is completed.

The new season fill begins in the third quarter and proceeds sequentially into the following spring, which is the peak period for crop fertilizer application.

As a result of this pattern, North American ammonium sulfate demand and pricing, particularly for our higher-value granular product, are typically strongest in the first half of the year through application for the spring crop and then decline in the second half of the year.

sulfate industry prices in the corn belt have declined approximately 10% from the second quarter to the third quarter, on average, since 2016.

Due to the ammonium sulfate fertilizer sales cycle, we occasionally build up higher inventory balances because our production is continuous throughout the year and not tied to seasonal demand for fertilizers.

Sales of most of our other products have generally been subject to minimal, or no, seasonality.

6 unchanged sentences

Further, although we believe that our sources of supply for our raw materials, including cumene, natural gas and sulfur, are generally robust, it is difficult to predict the impact that shortages, increased costs and related supply chain logistics considerations may have in the future.

In order to mitigate the risk of unplanned interruptions, we schedule several planned plant turnarounds each year to conduct routine and major maintenance across our facilities.

In order to mitigate the risk of unplanned interruptions, we schedule planned plant turnarounds each year to conduct routine and major maintenance across our facilities.

We also utilize maintenance excellence and mechanical integrity programs, targeted buffer inventory of intermediate chemicals necessary for our manufacturing process, and co-producer swap arrangements, which are intended to mitigate the extent of any production losses as a result of planned and unplanned downtime;

1 unchanged sentence

Recent Developments

Succession of Chief Accounting Officer

As previously reported, effective as of March 17, 2025, Christopher Gramm was appointed to serve as the Company’s Vice President, Financial Planning and Analysis.

In connection with his new role, Mr.

Gramm stepped down as the Company’s Vice President, Controller and will no longer serve as the Company’s principal accounting officer.

Effective as of March 17, 2025, the Company’s Board of Directors appointed Rachael E.

Ryan as the Company’s Vice President, Controller and Chief Accounting Officer to succeed Mr.

Succession of Chief Financial Officer

As previously reported, effective as of July 9, 2025, the Company’s Board of Directors (the “Board”) appointed Christopher Gramm as Interim Chief Financial Officer, replacing Siddharth Manjeshwar, whose employment as Senior Vice President and Chief Financial Officer was terminated on July 9, 2025.

The Company has commenced a search for a permanent successor.

Anti-Dumping Duty Petition - Acetone

17 unchanged sentences

Three Months Ended

June 30, Six Months Ended

2025 2024 2025 2024

Sales $ 410,022 $ 453,479 $ 787,813 $ 790,308

2 unchanged sentences

Three Months Ended

March 31, 2025

Sales increased in the three months ended March 31, 2025 compared to the prior year period by $41.0 million (approximately 12%) due to (i) increased volume (approximately 7%) driven by improved performance following the prior year operational disruption at the Frankford manufacturing site and higher ammonium sulfate sales supported by our SUSTAIN (Sustainable U.S.

Sulfate to Accelerate Increased Nutrition) program and (ii) favorable pricing (approximately 5%), including continued strength in Plant Nutrients reflecting favorable North American ammonium sulfate supply and demand conditions.

June 30, 2025 Six Months Ended

June 30, 2025

Volume (8.1)% (1.2)%

Price (1.5)% 0.9%

(9.6)% (0.3)%

Sales decreased in the three months ended June 30, 2025 compared to the prior year period by $43.5 million (approximately 10%) due to (i) decreased volume (approximately 8%) primarily driven by softer demand in key nylon end markets and (ii) lower raw material pass through pricing (approximately 5%) following a net cost decrease in benzene and propylene (inputs to cumene which is a key feedstock to our products), partially offset by favorable market-based pricing (approximately 3%) driven by continued strength in Plant Nutrients reflecting favorable North American ammonium sulfate supply and demand conditions.

Sales were approximately flat in the six months ended June 30, 2025 compared to the prior year period due to decreased volume (approximately 1%) driven by softer demand in key nylon end markets partially offset by higher granular ammonium sulfate sales supported by our SUSTAIN (Sustainable U.S.

Sulfate to Accelerate Increased Nutrition) program.

This was offset by higher pricing (approximately 1%), primarily reflecting favorable market-based pricing across our Plant Nutrients and Nylon Solutions product lines partially offset by lower raw material pass through pricing following a net cost decrease in benzene and propylene.

Costs of Goods Sold

Three Months Ended

June 30, Six Months Ended

2025 2024 2025 2024

Costs of goods sold $ 351,308 $ 372,111 $ 675,628 $ 705,975

1 unchanged sentence

Gross Margin percentage 14.3% 17.9% 14.2% 10.7%

Costs of goods sold decreased in the three months ended March 31, 2025 compared to the prior year period by $9.5 million (approximately 3%) due primarily to (i) insurance proceeds collected as a result of the PES supplier shutdown (approximately 8%) and (ii) decreased plant costs (approximately 6%) primarily driven by improved operational performance, partially offset by increased prices of raw materials, including natural gas and sulfur (approximately 6%) and increased sales volume (approximately 5%).

Gross margin percentage increased in the three months ended March 31, 2025 compared to the prior year period (approximately 13%) due primarily to (i) insurance proceeds collected as a result of the PES supplier shutdown (approximately 7%), (ii) decreased plant costs (approximately 5%) primarily driven by improved operational performance and (iii) increased sales volume (approximately 3%), partially offset by the impact of market-based pricing, net of raw material costs (approximately 1%).

Costs of goods sold decreased in the three months ended June 30, 2025 compared to the prior year period by $20.8 million (approximately 6%) due to decreased volume (approximately 9%) driven by lower nylon sales as a result of soft end market demand, partially offset by (i) increased operational costs (approximately 2%) driven by utility spend and (ii) increased raw material costs (approximately 1%) driven by natural gas and sulfur.

Costs of goods sold decreased in the six months ended June 30, 2025 compared to the prior year period by $30.3 million (approximately 4%) due to (i) insurance proceeds collected as a result of the PES supplier shutdown (approximately 4%), (ii) decreased operational costs (approximately 2%) primarily driven by improved operational performance, and (iii) decreased sales volume (approximately 2%), partially offset by increased raw material costs (approximately 3%) driven by natural gas and sulfur.

Gross margin percentage decreased in the three months ended June 30, 2025 compared to the prior year period (approximately 4%) due primarily to (i) increased plant costs (approximately 2%) driven by utility spend and (ii) the impact of market-based pricing, net of raw material costs (approximately 2%).

Gross margin percentage increased by approximately 4% in the six months ended June 30, 2025 compared to the prior year period due to (i) insurance proceeds collected as a result of the PES supplier shutdown (approximately 3%), (ii) decreased plant costs (approximately 1%) primarily driven by improved operational performance, and (iii) the net impact of lower sales volume and change in sales mix (approximately 1%), partially offset by the impact of market-based pricing, net of raw material costs (approximately 2%).

Selling, General and Administrative Expenses

Three Months Ended

June 30, Six Months Ended

2025 2024 2025 2024

Selling, general and administrative expenses $ 25,416 $ 24,431 $ 48,825 $ 48,024

Percentage of Sales 6.2% 5.4% 6.2% 6.1%

Selling, general and administrative expenses decreased slightly in the three months ended March 31, 2025 compared to the prior year period.

Selling, general and administrative expenses increased by $1.0 million in the three months ended June 30, 2025 compared to the prior year period due primarily to the planned investment to upgrade our enterprise resource planning system.

Selling, general and administrative expenses increased by $0.8 million in the six months ended June 30, 2025 compared to the prior period due primarily to the planned investment to upgrade our enterprise resource planning system.

Income Tax Expense

Three Months Ended

Income tax expense (benefit) $ 5,585 $ (6,021)

June 30, Six Months Ended

2025 2024 2025 2024

Income tax expense $ 279 $ 13,145 $ 5,864 $ 7,124

Effective tax rate 0.9% 25.2% 9.7% 24.9%

The Company’s provision (benefit) for income taxes in interim periods is computed by applying an estimated annual effective tax rate against Income before taxes for the period in addition to recording any tax effects of discrete items for the quarter.

The Company’s effective tax rate for the three months ended March 31, 2025 differed from the U.S.

The Company’s provision for income taxes in interim periods is computed by applying an estimated annual effective tax rate against Income before taxes for the period in addition to recording any tax effects of discrete items for the quarter.

The Company’s effective tax rate for the three and six months ended June 30, 2025 differed from the U.S.

federal statutory rate due to state taxes and executive compensation deduction limitations which generally increase the rate, offset by research tax credits that generally decrease the rate.

Additionally, discrete tax adjustments recorded in the quarter related to Internal Revenue Code (IRC) Section 45Q tax credits of $1.8 million, offset slightly by state tax legislation changes had a net 5.8% decrease on the rate.

The Company’s effective tax rate for the three months ended March 31, 2024 was higher than the U.S.

federal statutory rate, due to the impacts of state taxes and executive compensation deduction limitations, partially offset by tax credits.

The Company’s effective tax rate for the three months ended March 31, 2025 was lower than the prior year period due primarily to the impact of the IRC Section 45Q tax credits recorded in the current year.

The Company continues to monitor any potential new tax legislation that could result in a material impact on its financial statements including the U.S.

House of Representatives approval of the fiscal year 2025 budget resolution on April 10, 2025.

This approval clears the way for substantive action by House and Senate Republicans to advance legislation that would potentially address expiring Tax Cuts and Jobs Act provisions and incorporate other tax proposals.

Net Income (Loss)

Additionally, discrete tax adjustments recorded in the first and second quarter of the year related to Internal Revenue Code (IRC) Section 45Q tax credits of $1.8 million and $7.9 million, respectively, offset slightly by state tax legislation resulted in a net 24.7% and 15.7% decrease in the rate for the three and six months ended June 30, 2025, respectively.

The Company’s effective tax rate for the three and six months ended June 30, 2024 was higher than the U.S.

federal statutory rate, due to the impacts of state taxes and executive compensation deduction limitations which generally increase the tax rate, partially offset by tax credits which generally decrease the tax rate.

The Company’s effective tax rate for the three and six months ended June 30, 2025 was lower than the prior year period due primarily to the impact of the IRC Section 45Q tax credits recorded in the first half of the current year compared to the first half of the prior year.

On July 4, 2025, President Trump signed into law legislation commonly referred to as the One Big Beautiful Bill Act (the "Act"), which includes numerous tax reform provisions affecting businesses, including extending and modifying certain provisions of the Tax Cuts and Jobs Act (both domestic and international), while also introducing major changes to federal energy policy by rolling back many clean energy provisions enacted as part of the Inflation Reduction Act.

The Act includes a broad array of business-related provisions, including the full expensing of domestic research and experimental expenditures (i.e., R&D costs), modification of the limitation on business interest and making permanent full expensing for certain business property (i.e., 100 percent bonus depreciation).

While we do not currently anticipate that the clean energy provisions will have a material impact on our financial results, we continue to evaluate these provisions.

However, we do anticipate that the changes to R&D costs and the 100 percent bonus deprecation provisions will result in lower cash taxes in future periods.

Due to the elective applicability of these provisions, we are still in the process of modeling and performing a full evaluation before determining the full impact and timing that these provisions will have on our financial results.

Since the Act was enacted after the June 30 period-end date, no provisions are accounted for in our current financial statements.

Due to the variety of effective dates for key provisions, we anticipate only certain provisions will impact our third and fourth quarter financial statements but the Company is unable to reasonably estimate the full impact of the Act on its financial statements at this time.

Three Months Ended

Net income (loss) $ 23,344 $ (17,396)

As a result of the factors described above, Net income (loss) was $23.3 million for the three months ended March 31, 2025 as compared to $(17.4) million in the corresponding prior year period.

June 30, Six Months Ended

2025 2024 2025 2024

Net income $ 31,371 $ 38,927 $ 54,715 $ 21,531

As a result of the factors described above, Net income was $31.4 million and $54.7 million for the three and six months ended June 30, 2025, respectively, as compared to $38.9 million and $21.5 million in the corresponding prior year period.

Non-GAAP Measures

11 unchanged sentences

Three Months Ended

Net income (loss) $ 23,344 $ (17,396)

June 30, Six Months Ended

2025 2024 2025 2024

Net income $ 31,371 $ 38,927 $ 54,715 $ 21,531

Non-cash stock-based compensation 2,309 2,193 4,287 4,404

Non-recurring, unusual or extraordinary (income) expense — —

Non-recurring, unusual or extraordinary expense* — 1,200 — 1,200

Non-cash amortization from acquisitions 531 532 1,063 1,064

1 unchanged sentence

Income tax benefit relating to reconciling items (479) (762) (909) (1,227)

Adjusted Net income (loss) (non-GAAP) 25,424 (15,118)

Adjusted Net income (non-GAAP) 33,732 42,090 59,156 26,972

Interest expense, net 2,255 3,514 3,796 6,213

Income tax expense (benefit) - Adjusted 6,015 (5,556)

Income tax expense - Adjusted 758 13,907 6,773 8,351

Depreciation and amortization - Adjusted 18,930 18,630 37,576 37,200

2 unchanged sentences

Adjusted EBITDA Margin** (non-GAAP) 13.6% 17.2% 13.6% 10.0%

* 2024 includes a pre-tax loss of approximately $1.2 million from the reduction of the Company's anticipated receivable related to the gain on the termination fee recorded upon the exit from the Oben Holding Group S.A.

alliance during the third quarter of 2023.

** Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by Sales.

2 unchanged sentences

Three Months Ended

Net income (loss) $ 23,344 $ (17,396)

Adjusted Net income (loss) (non-GAAP) 25,424 (15,118)

June 30, Six Months Ended

2025 2024 2025 2024

Net income $ 31,371 $ 38,927 $ 54,715 $ 21,531

Adjusted Net income (non-GAAP) 33,732 42,090 59,156 26,972

Weighted-average number of common shares outstanding - basic 26,896,037 26,839,429 26,867,252 26,859,044

7 unchanged sentences

(Dollars in thousands, unless otherwise noted)

We believe that cash balances and operating cash flows, together with available capacity under our credit agreement, as utilized in the first quarter of 2025, will provide adequate funds to support our current short-term operating objectives as well as our longer-term strategic plans, subject to the risks and uncertainties outlined below, in our "Note Regarding Forward-Looking Statements" above, and in the risk factors previously disclosed in Item 1A of Part I of our 2024 Form 10-K.

Our principal source of liquidity is our cash flow generated from operating activities, which is expected to provide us with the ability to meet

the majority of our short-term funding requirements.

We believe that cash balances and operating cash flows, together with available capacity under our credit agreement, as utilized in the second quarter of 2025, will provide adequate funds to support our current short-term operating objectives as well as our longer-term strategic plans, subject to the risks and uncertainties outlined below, in our "Note Regarding Forward-Looking Statements" above, and in the risk factors previously disclosed in Item 1A of Part I of our 2024 Form 10-K.

Our principal source of liquidity is our cash flow generated from operating activities, which is expected to provide us with the ability to meet the majority of our short-term funding requirements for the next twelve months and beyond.

Our cash flows are affected by capital requirements and production volume, which may be materially impacted by unanticipated events such as unplanned downtime, material disruptions at our production facilities, the prices of our raw materials, general economic and industry trends and customer demand.

9 unchanged sentences

Our ability to fund our capital needs, however, will depend on our ongoing ability to generate cash from operations and access to credit and capital markets, both of which are subject to the risk factors previously disclosed in Item 1A of Part I of our 2024 Form 10-K, as well as general economic, financial, competitive, regulatory and other factors that are beyond our control.

As of the end of the first quarter of 2025, the Company had approximately $8.3 million of cash on hand with approximately $284 million of additional capacity available under the revolving credit facility.

As of the end of the second quarter of 2025, the Company had approximately $18.4 million of cash on hand with approximately $259 million of additional capacity available under the revolving credit facility.

The Company’s Consolidated Leverage Ratio financial covenant of its credit facility allows it to net up to $75 million of cash with debt.

Capital expenditures are expected to be approximately $145 million to $155 million in 2025 compared to $134 million in 2024, reflecting the planned progression of our SUSTAIN growth program, and refined execution timing to address critical enterprise risk mitigation.

Capital expenditures are expected to

be approximately $135 million to $145 million in 2025 compared to $134 million in 2024, reflecting the planned progression of our SUSTAIN growth program, and refined execution timing to address critical enterprise risk mitigation.

We assumed from Honeywell International Inc.

3 unchanged sentences

We expect that our primary cash requirements for 2025 will be to fund costs associated with ongoing operations, capital expenditures, and amounts related to other contractual obligations.

The Company made no cash contributions to the defined benefit pension plan during the three months ended March 31, 2025 as there were no funding requirements for the period.

The Company made no cash contributions to the defined benefit pension plan during the six months ended June 30, 2025 as there were no funding requirements for the period.

Additional contributions may be made in future periods sufficient to satisfy pension funding requirements in those periods or on a discretionary basis.

On February 17, 2023, the Company's Board of Directors (the "Board") authorized a share repurchase program to repurchase shares of the Company's common stock.

As of March 31, 2025, the Company has repurchased a total of 6,305,561 shares of common stock life-to-date, including 1,060,105 shares withheld to cover tax withholding obligations in connection with the vesting of awards, for an aggregate of $193.9 million at a weighted average market price of $30.75 per share.

As of March 31, 2025, approximately $62.0 million remained available for share repurchases under the currently authorized repurchase program.

During the period April 1, 2025 through April 25, 2025, 2,538 additional shares were repurchased for tax withholding obligations in connection with the vesting of equity awards at a weighted average market price of $20.05 and no additional shares were repurchased under the currently authorized repurchase program.

On February 17, 2023, the Board authorized a share repurchase program to repurchase shares of the Company's common stock.

As of June 30, 2025, the Company has repurchased a total of 6,308,099 shares of common stock life-to-date, including 1,062,643 shares withheld to cover tax withholding obligations in connection with the vesting of awards, for an aggregate of $194.0 million at a weighted average market price of $30.75 per share.

As of June 30, 2025, approximately $62.0 million remained available for share repurchases under the currently authorized repurchase program.

During the period July 1, 2025 through July 25, 2025, no additional shares were repurchased for tax withholding obligations or under the currently authorized repurchase program.

Repurchases may be made from time to time on the open market in accordance with Rule 10b-18 of the Exchange Act, including through the use of trading plans intended to qualify under Rule 10b5-1 of the Exchange Act.

1 unchanged sentence

The share repurchase program has no expiration date and may be modified, suspended or discontinued at any time.

value of the shares repurchased is applied to Treasury stock and the excess of the purchase price over par value is applied to Additional paid-in capital.

As of March 31, 2025, the Company did not have any off-balance sheet arrangements as described in Instruction 8 to Item 303(b) of Regulation S-K and did not have any material changes in the commitments or contractual obligations detailed in the Company's 2024 Form 10-K (see Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" under "Liquidity and Capital Resources - Liquidity").

The par value of the shares repurchased is applied to Treasury stock and the excess of the purchase price over par value is applied to Additional paid-in capital.

As of June 30, 2025, the Company did not have any off-balance sheet arrangements as described in Instruction 8 to Item 303(b) of Regulation S-K and did not have any material changes in the commitments or contractual obligations detailed in the 2024 Form 10-K (see Part II, Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" under "Liquidity and Capital Resources - Liquidity").

The Company has not guaranteed any debt or commitments of other entities or entered into any options on non-financial assets.

4 unchanged sentences

5/2/2025 5/13/2025 5/27/2025 $0.16 $4.3

2/21/2025 3/10/2025 3/24/2025 $0.16 $4.3

The timing, declaration, amount and payment of future dividends to stockholders, if any, will fall within the discretion of our Board.

Holders of shares of our common stock will be entitled to receive dividends when, and if, declared by our Board at its discretion out of funds legally available for that purpose, subject to the terms of our indebtedness, the preferential rights of any preferred stock that may be outstanding, legal requirements, regulatory constraints, industry practice and other factors that our Board deems relevant.

preferred stock that may be outstanding, legal requirements, regulatory constraints, industry practice and other factors that our Board deems relevant.

Credit Agreement

1 unchanged sentence

Borrowings under the Revolving Credit Facility are subject to customary borrowing conditions.

The Revolving Credit Facility has a scheduled maturity date of October 27, 2026.

The Revolving Credit Facility has a scheduled maturity date of October 27, 2026, which the Company expects to refinance before such date.

The Credit Agreement permits the Company to utilize up to $40 million of the Revolving Credit Facility for the issuance of letters of credit and up to $40 million for swing line loans.

4 unchanged sentences

The Credit Agreement contains customary covenants limiting the ability of the Company and its subsidiaries to, among other things, pay cash dividends, incur debt or liens, redeem or repurchase stock of the Company, enter into transactions with affiliates, make investments, make capital expenditures, merge or consolidate with others or dispose of assets.

The Credit Agreement also contains financial covenants that require the Company to maintain a Consolidated Interest Coverage Ratio (as

defined in the Credit Agreement) of not less than 3.00 to 1.00 and to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less (subject to the Company’s option to elect a consolidated leverage ratio increase in connection with certain acquisitions).

The Credit Agreement also contains financial covenants that require the Company to maintain a Consolidated Interest Coverage Ratio (as defined in the Credit Agreement) of not less than 3.00 to 1.00 and to maintain a Consolidated Leverage Ratio of 3.75 to 1.00 or less (subject to the Company’s option to elect a consolidated leverage ratio increase in connection with certain acquisitions).

If the Company does not comply with the covenants in the Credit Agreement, the lenders may, subject to customary cure rights, require the immediate payment of all amounts outstanding under the Revolving Credit Facility.

We were in compliance with all of our covenants at March 31, 2025 and through the date of the filing of this Form 10-Q.

We were in compliance with all of our covenants at June 30, 2025 and through the date of the filing of this Form 10-Q.

We had a borrowed balance of $195 million under the Revolving Credit Facility at December 31, 2024.

We borrowed an incremental net amount of $20 million during the three months ended March 31, 2025, bringing the balance under the Revolving Credit Facility to $215 million, and available credit for use of approximately $284 million as of March 31, 2025.

We borrowed an incremental net amount of $45 million during the six months ended June 30, 2025, bringing the balance under the Revolving Credit Facility to $240 million, and available credit for use of approximately $259 million as of June 30, 2025.

We expect that Cash provided by operating activities will fund future interest payments on the Company's outstanding indebtedness.

Cash Flow Summary

Three Months Ended

Six Months Ended

Cash provided by (used for):

3 unchanged sentences

Net change in cash and cash equivalents $ (1,118) $ (17,663)

Cash provided by operating activities increased by $47.6 million for the three months ended March 31, 2025 versus the prior year period due primarily to (i) a $40.7 million increase in net income, (ii) the favorable cash impact of $7.7 million from Taxes receivable and Income taxes payable combined, driven by the timing of tax payments and (iii) a $6.6 million favorable cash impact from working capital (comprised of Accounts and other receivables, Inventories, Accounts payable and Deferred income and customer advances) with a $35.7 million unfavorable cash impact from working capital for the three months ended March 31, 2025 compared to a $42.3 million unfavorable cash impact in the prior year period due primarily to the favorable impact of Accounts payable partially offset by Inventory, Accounts and other receivables and Deferred income and customer advances.

These net favorable impacts were partially offset by a $7.1 million unfavorable cash impact from accrued liabilities due primarily to the timing of payments and accruals during the three months ended March 31, 2025 related to other accrued liabilities compared to the prior year period.

Cash used for investing activities was approximately flat for the three months ended March 31, 2025 versus the prior year period for capital expenditures and other enterprise programs.

Cash provided by financing activities decreased by $49.7 million for the three months ended March 31, 2025 versus the prior year period due primarily to net borrowings of $20.0 million during the three months ended March 31, 2025 compared to net borrowings of $75.0 million during the prior year period, partially offset by payments for share repurchases of $1.5 million during the three months ended March 31, 2025 compared to $7.0 million during the prior year period.

Cash paid for dividends was relatively unchanged year-over-year.

Cash provided by operating activities increased by $18.6 million for the six months ended June 30, 2025 versus the prior year period due primarily to a $33.2 million increase in net income, partially offset by (i) the unfavorable cash impact of $9.6 million from Taxes receivable and Income taxes payable combined, driven by the timing of tax payments and (ii) a $5.6 million

unfavorable cash impact from Accrued liabilities due primarily to the timing of payments and accruals during the six months ended June 30, 2025 compared to the prior year period.

Cash used for investing activities decreased by $4.4 million for the six months ended June 30, 2025 versus the prior year period due primarily to the timing of cash payments for capital expenditures and other enterprise programs.

Cash provided by financing activities decreased by $6.4 million for the six months ended June 30, 2025 versus the prior year period due primarily to net borrowings of $45.0 million during the six months ended June 30, 2025 compared to net borrowings of $60.0 million during the prior year period, partially offset by payments for share repurchases of $1.5 million during the six months ended June 30, 2025 compared to $10.4 million during the prior year period.

Capital Expenditures

2 unchanged sentences

The following table summarizes ongoing and expansion capital expenditures:

Three Months Ended

March 31, 2025

Six Months Ended

June 30, 2025

Capital expenditures in Accounts payable at December 31, 2024

Purchases of property, plant and equipment 53,444

Capital expenditures in Accounts payable at March 31, 2025

Capital expenditures in Accounts payable at June 30, 2025

Cash paid for capital expenditures $ 62,327

10 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis